Karachi, Pakistan

Kanwal Iftikhar

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kanwal Iftikhar. Retrieved from https://idiyas.com/inventor/kanwal-iftikhar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,570 
Other
 patents

Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kanwal Iftikhar: Innovator in Neurogenesis Treatment

Introduction

Kanwal Iftikhar is a notable inventor based in Karachi, Pakistan. He has made significant contributions to the field of neurogenesis, particularly in the treatment of neurodegenerative diseases. His innovative approach focuses on stimulating neurogenesis through the use of isoxylitones.

Latest Patents

Kanwal Iftikhar holds a patent for his invention titled "Isoxylitones Mediated Neurogenesis." This invention provides an effective method and composition for treating neurodegenerative diseases and conditions of the central and peripheral nervous system. It aims to stimulate neurogenesis by utilizing isoxylitones or their isomers, acid analogs, salts, or solvates. He has 1 patent to his name.

Career Highlights

Throughout his career, Kanwal has demonstrated a commitment to advancing medical science. His work has the potential to impact the lives of many individuals suffering from neurodegenerative conditions. He continues to explore innovative solutions in this critical area of research.

Collaborations

Kanwal has collaborated with notable individuals in his field, including Anila Bashir and Atta-ur-Rahman. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in neurogenesis research.

Conclusion

Kanwal Iftikhar is a pioneering inventor whose work in neurogenesis treatment holds promise for the future of medicine. His dedication to innovation and collaboration is commendable, and his contributions are likely to have a lasting impact on the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…